These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7562396)

  • 1. [Basic study and application of functional liposomes].
    Oku N
    Yakugaku Zasshi; 1995 Jul; 115(7):483-98. PubMed ID: 7562396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of reticuloendothelial system (RES)-avoiding liposomes containing a phospholipid analogue of 5-fluorouracil, dipalmitoylphosphatidylfluorouridine, in Meth A sarcoma-bearing mice.
    Doi K; Oku N; Toyota T; Shuto S; Sakai A; Itoh H; Okada S
    Biol Pharm Bull; 1994 Oct; 17(10):1414-6. PubMed ID: 7874068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor imaging with technetium-99m-DTPA encapsulated in RES-avoiding liposomes.
    Oku N; Namba Y; Takeda A; Okada S
    Nucl Med Biol; 1993 May; 20(4):407-12. PubMed ID: 8504283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-circulating liposomes.
    Oku N; Namba Y
    Crit Rev Ther Drug Carrier Syst; 1994; 11(4):231-70. PubMed ID: 7664348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal modification with uronate, which endows liposomes with long circulation in vivo, reduces the uptake of liposomes by J774 cells in vitro.
    Namba Y; Oku N; Ito F; Sakakibara T; Okada S
    Life Sci; 1992; 50(23):1773-9. PubMed ID: 1598066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor accumulation of novel RES-avoiding liposomes.
    Oku N; Namba Y; Okada S
    Biochim Biophys Acta; 1992 Jun; 1126(3):255-60. PubMed ID: 1637853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-sensitive liposomes--principle and application in cancer therapy.
    Karanth H; Murthy RS
    J Pharm Pharmacol; 2007 Apr; 59(4):469-83. PubMed ID: 17430630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic Acid-Based pH-Sensitive Polymer-Modified Liposomes for Cell-Specific Intracellular Drug Delivery Systems.
    Miyazaki M; Yuba E; Hayashi H; Harada A; Kono K
    Bioconjug Chem; 2018 Jan; 29(1):44-55. PubMed ID: 29183110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
    Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
    Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
    Andresen TL; Jensen SS; Jørgensen K
    Prog Lipid Res; 2005 Jan; 44(1):68-97. PubMed ID: 15748655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimuli-responsive Smart Liposomes in Cancer Targeting.
    Jain A; Jain SK
    Curr Drug Targets; 2018 Feb; 19(3):259-270. PubMed ID: 26853324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-sensitive liposomes for drug delivery in cancer treatment.
    Ferreira Ddos S; Lopes SC; Franco MS; Oliveira MC
    Ther Deliv; 2013 Sep; 4(9):1099-123. PubMed ID: 24024511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted liposomal drug delivery in cancer.
    Medina OP; Zhu Y; Kairemo K
    Curr Pharm Des; 2004; 10(24):2981-9. PubMed ID: 15379663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of 5'-O-dipalmitoylphosphatidyl 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine is enhanced by long-circulating liposomalization.
    Asai T; Kurohane K; Shuto S; Awano H; Matsuda A; Tsukada H; Namba Y; Okada S; Oku N
    Biol Pharm Bull; 1998 Jul; 21(7):766-71. PubMed ID: 9703265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes.
    Moku G; Gulla SK; Nimmu NV; Khalid S; Chaudhuri A
    Biomater Sci; 2016 Apr; 4(4):627-38. PubMed ID: 26806172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A review on the influences of size and surface charge of liposome on its targeted drug delivery in vivo].
    Yang YF; Xie XY; Yang Y; Zhang H; Mei XG
    Yao Xue Xue Bao; 2013 Nov; 48(11):1644-50. PubMed ID: 24475700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane modification by negatively charged stearyl-polyoxyethylene derivatives for thermosensitive liposomes: reduced liposomal aggregation and avoidance of reticuloendothelial system uptake.
    Iga K; Ohkouchi K; Ogawa Y; Toguchi H
    J Drug Target; 1994; 2(3):259-67. PubMed ID: 7812694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional Liposomes.
    Aryasomayajula B; Salzano G; Torchilin VP
    Methods Mol Biol; 2017; 1530():41-61. PubMed ID: 28150195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods.
    Agarwal A; Mackey MA; El-Sayed MA; Bellamkonda RV
    ACS Nano; 2011 Jun; 5(6):4919-26. PubMed ID: 21591812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.